Let's take a look at Exhibit "E".
Dr. Lalezari Emails Jeff Murray That COVID is a RANTES Disease
Virginia coaching Jeff about expected elevated levels of cytokines, not realizing that leronlimab obliterates elevated levels of RANTES. She Reinforces to Murray that CytoDyn & Amarex as "fake". Debra is planning on writing a book or a movie they imagine is happening. They are flabbergasted that Gilead was brought into the email thread. Why should it not be? Were you trying to hide something from CytoDyn? Obviously, you hid it well, since CytoDyn brough it up. 4 question marks???? What are you saying Kim? Murray remains oblivious and still can't see the big picture.
Dr. Lalezari Knew Then Leronlimab to have Anti-Viral & Anti-Inflammatory Capability
Lalezari knows leronlimab would affect outcomes far better. He was even considering the combination of leronlimab with an antiviral, not that it was even necessary, as we know now that leronlimab has anti-viral properties.
Scott Kelly Writing To Jonah Sacha Regarding Gilead/Remdesivir/Fierce Biotech
Gilead supersizes remdesivir trials, changes primary endpoint | Fierce Biotech
Here Scott Kelly brings up Gilead. He considers it "odd" that Gilead changed their trial size and their primary endpoints. He makes mention of the poor side effect profile that remdesivir has especially regarding renal/kidney and liver failure. Despite this, Gilead was permitted to completely modify this trial.
Gilead had to get their remdesivir approved. Fishy Fauci made his mind up on which drug would get the EUA to help treat COVID. It never would have been approved using the previous trial size and previous endpoints. They had to be changed to suit the performance of the drug. They needed many more patients and a different endpoint. And the trial was permitted to be changed. Gilead was permitted to bend the rules while all the other potential drug candidates were slow walked and had significant obstacles put before them. When has this ever occurred in drug making history?
Right after Gilead modified their remdesivir trial, CytoDyn has the meeting with the authority that following the 2nd leronlimab injection on the 7th day of treatment, there would be no more further injections, yet, the endpoint, would still happen around day 30. So, day 0 and day 7 were the days for leronlimab treatment, but nothing on day 14 and nothing on day 21, but the assessment would still take place on day 28 or so. No bending of the rules for CytoDyn. 24 days of no treatment, then measure and assess. Yeah, that is fair. Gilead completely overhauls their trial with no questions asked while CytoDyn has to jump through hoops to clear the bar.
Bruce Proves COVID is a RANTES Disease
Bruce proves COVID is a RANTES disease. This means that leronlimab just so happens to treat COVID at its root. At the point of its origin. From where it is manifested. This sunk deep into the understanding of Dr. Lalezari. Maybe this is why he may have stormed out from that meeting with the authority saying, "there will be blood on your hands." Is there something here SA might have on the authority or on Gilead? Is it worth pursuing? Why don't other Big Pharmaceuticals say or do anything when they see the unfair treatment, the favoritism showered upon Gilead while all others are made to trudge through the mud?
Posted Apr 21, 2024, 10:44 AM UTC